Olga Camacho‐Vanegas

Author

Icahn School of Medicine at Mount Sinai

Also Known As

A.M. Faussat, O Camacho-Vanegas, O. Camacho-Vanegas, O. Camachovanegas, Olga Camacho-Vanegas, Olga Camacho‐Vanegas

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Immunovaccine (Canada)Western Connecticut Health Network University of Rome Tor Vergata Swift Engineering (United States)

About

Olga Camacho‐Vanegas is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	306
2	Cell Biology	4	4	222
3	Health Sciences	1	1	67
4	Natural Sciences	1	1	21
5	Immunology	1	1	11

Olga Camacho‐Vanegas

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis John A. Martignetti, Lifeng Tian, Dong Li, The American Journal of Human Genetics Mendelian DisorderGenetic DisorderPathologyMolecular DiagnosticsInborn Error Of Immunity	2013	204
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers Elena Pereira, Olga Camacho‐Vanegas, Sanya Anand, PLoS ONE	2015	174
Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread Goutham Narla, Analisa DiFeo, Shen Yao, Cancer Research	2005	165
Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination Analisa DiFeo, Goutham Narla, Jennifer Hirshfeld, Clinical Cancer Research	2006	107
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study Navya Nair, Olga Camacho‐Vanegas, Dmitry Rykunov, PLoS Medicine	2016	98
Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma Olga Camacho‐Vanegas, Goutham Narla, Miriam S. Teixeira, International Journal of Cancer	2007	80
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor Analisa DiFeo, Goutham Narla, Olga Camacho‐Vanegas, Oncogene Cancer ResearchSignal TransductionSignaling PathwayCell RegulationMedicine	2006	74
Morbid Obesity Resulting from Inactivation of the Ciliary Protein CEP19 in Humans and Mice Adel Shalata, Maria Celeste M. Ramirez, Robert J. Desnick, The American Journal of Human Genetics ObesityMetabolic SyndromeCiliary Protein Cep19PhysiologyPathology	2013	67
Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA John A. Martignetti, Olga Camacho‐Vanegas, Nolan Priedigkeit, Neoplasia Endocrine-related CancerCancer DetectionCirculating Tumor DnaMedicineFgfr2 Fusion	2014	60
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression Deep Agnani, Olga Camacho‐Vanegas, Catalina Camacho, Journal of Ovarian Research	2011	53

Page 1